Biznesradar bez reklam? Sprawdź BR Plus
Notowania JNJ.US
207.01+0.10(+0.05%)(czas lokalny: 31.12.2025 16:00)Johnson & Johnson
WERSJA BETA
NYSE
Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
| Data: | |
|---|---|
| Kurs: | 207.01 |
| Otwarcie: | 207.02 |
| Min: | 206.40 |
| Max: | 207.50 |
| Wolumen: | 79 058 |
| Min 52 tyg: | 141.00 |
| Max 52 tyg: | 215.16 |
| Zmiana | Zmiana % | Kurs odn. | Data odn. | |
|---|---|---|---|---|
| Zmiana 1d: | +0.10 | (+0.05%) | 206.91 | 30.12.2025 |
| Zmiana 7d: | +1.24 | (+0.61%) | 205.76 | 23.12.2025 |
| Zmiana 1m: | +0.06 | (+0.03%) | 206.95 | 28.11.2025 |
| Zmiana 3m: | +25.36 | (+13.96%) | 181.65 | 29.09.2025 |
| Zmiana YTD: | -0.00 | (-0.00%) | 207.01 | 31.12.2025 |
| Zmiana 12m: | +63.68 | (+44.43%) | 143.33 | 30.12.2024 |
| porównaj stopy zwrotu » | ||||
WSKAŹNIKI AT
neutralnie
31 gru 22:00
mówią wskaźniki
| RSI(14) | sprzedaj |
| STS(14,3) | sprzedaj |
| MACD(12,26,9) | sprzedaj |
| TRIX(14,9) | sprzedaj |
| Williams %R(10) | kupuj |
interwał dzienny
zobacz więcej wskaźników »
SYGNAŁY AT
|
FI > 0
|
24 gru 19:00 |
|
ROC > 0
|
22 gru 22:00 |
|
FI < 0
|
19 gru 22:00 |
|
ROC < 0
|
19 gru 22:00 |
|
MACD < SIGNAL
|
18 gru 22:00 |
|
RSI < 70
|
16 gru 22:00 |
|
Williams %R < -20
|
16 gru 22:00 |
interwał dzienny
zobacz więcej sygnałów »
FORMACJE ŚWIECOWE
TRENDY
| 3m |  |
Trend boczny |
| 6m |  |
Trend wzrostowy |
| 12m |  |
Mocny trend wzrostowy |
| 24m |  |
Trend wzrostowy |
| 36m |  |
Trend boczny |
STOPY ZWROTU
| stopa zwrotu | w stosunku do S&P 500 | |
|---|---|---|
| 1m | +0.03% | +0.08% |
| 3m | +13.96% | +11.19% |
| 6m | +35.82% | +24.87% |
| 12m | +44.43% | +28.54% |
| 24m | +32.07% | -11.36% |
| 36m | +17.19% | -61.15% |
OSTATNIE WIADOMOŚCI
Johnson & Johnson (NYSE: JNJ) reported its third quarter 2025 earnings results today. Reported sales increased 6.8% year-over-year to $24 billion. Operational sales were up 5.4%. GAAP net earnings rose 91% to $5.2 billion, or $2.12 per share, compared to last year. Adjusted EPS grew 16% to $2.80. For the full year of 2025, reported […]
The post JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q3 2025 financial results first appeared on AlphaStreet.
For Johnson & Johnson (NYSE: JNJ), 2025 has been a strong year, marked by an impressive financial performance that drove the stock sharply higher mid-year. Investors will be keeping a close watch on the healthcare behemoth’s third-quarter earnings to check how it deals with macroeconomic challenges. The positive sentiment also reflects the company’s limited exposure […] The post Innovation pipeline, portfolio in focus ahead of Johnson & Johnson’s Q3 earnings first appeared on...
Johnson & Johnson (NYSE: JNJ) reported its second quarter 2025 earnings results today. Reported sales increased 5.8% year-over-year to $23.7 billion. Operational sales growth was 4.6%. Net earnings grew over […]
The post Key highlights from Johnson & Johnson’s (JNJ) Q2 2025 earnings results first appeared on AlphaStreet.
Johnson & Johnson’s (NYSE: JNJ) business strategy for fiscal 2025 is focused on reducing the impact of patent expirations on its revenue. Anticipating sales to benefit from growth initiatives, including […]
The post Johnson & Johnson to report Q2 earnings on July 16. Here’s what to expect first appeared on AlphaStreet.
Johnson & Johnson (NYSE: JNJ) reported its first quarter 2025 earnings results today. Reported sales increased 2.4% year-over-year to $21.8 billion. Operational sales growth was 4.2%. Net earnings rose to […]
The post JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2025 financial results first appeared on AlphaStreet.
Dowiedz się więcej o wskaźnikach analizy technicznej i wykresach punktowo-symbolicznych.
